These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24176828)

  • 1. Coagulation and complications of left ventricular assist device therapy: a primer for emergency nurses.
    Newsom LC; Paciullo CA
    Adv Emerg Nurs J; 2013; 35(4):293-300; quiz 301-2. PubMed ID: 24176828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
    J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.
    Slaughter MS; Pagani FD; Rogers JG; Miller LW; Sun B; Russell SD; Starling RC; Chen L; Boyle AJ; Chillcott S; Adamson RM; Blood MS; Camacho MT; Idrissi KA; Petty M; Sobieski M; Wright S; Myers TJ; Farrar DJ;
    J Heart Lung Transplant; 2010 Apr; 29(4 Suppl):S1-39. PubMed ID: 20181499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.
    Jennings DL; Weeks PA
    Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation management in patients undergoing mechanical circulatory support.
    Görlinger K; Bergmann L; Dirkmann D
    Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):179-98. PubMed ID: 22910089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device management in the ICU.
    Pratt AK; Shah NS; Boyce SW
    Crit Care Med; 2014 Jan; 42(1):158-68. PubMed ID: 24240731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and bleeding in patients with ventricular assist devices: walking the tightrope.
    Kurien S; Hughes KA
    AACN Adv Crit Care; 2012; 23(1):91-8. PubMed ID: 22290095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of bleeding-related morbidity with left ventricular assist device implantation in the current era.
    Krishan K; Nair A; Pinney S; Adams D; Anyanwu AC
    Artif Organs; 2012 Aug; 36(8):746-51. PubMed ID: 22607225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined administration of protease inhibitor and thromboxane A2 synthetase inhibitor for anticoagulation of a left ventricular assist device.
    Takahama T; Kanai F; Hiraishi M; Onishi K; Yamazaki Z; Naruse Y; Furuse A; Yoshitake T
    ASAIO Trans; 1990; 36(3):M141-4. PubMed ID: 2252644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HeartMate® II continuous-flow left ventricular assist system.
    Sheikh FH; Russell SD
    Expert Rev Med Devices; 2011 Jan; 8(1):11-21. PubMed ID: 21158536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
    Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
    J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
    Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.